Interpace Biosciences, Inc.: Revision history

20 August 2022

• curprev 04:0004:00, 20 August 2022 95.149.241.133 talk 1,260 bytes +11 No edit summary undo

13 August 2022

• curprev 04:1604:16, 13 August 2022 109.180.50.163 talk 1,249 bytes +15 No edit summary undo

5 August 2022

• curprev 22:5522:55, 5 August 2022 >Paris 1,234 bytes +1,234 Created page with "Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians better assess risk of pancreaticobiliary cancers using its PathFinderTG platform; PanDNA, a molecular only version of PancraGEN that provides physicians a snapshot of a limited number of factors; and Thy..."